XtalPi and Microsoft China Sign Strategic Collaboration Memorandum to Advance AI-Driven Innovation in Life Sciences, New Materials, and Education
XtalPi
Computation-Driven Innovative Drug R&D Provider
On December 16, XtalPi and Microsoft China announced the signing of a strategic cooperation memorandum, aiming to leverage cutting-edge technologies such as artificial intelligence (AI), large models, and robotic laboratories to explore innovative applications of these technologies in the fields of biomedicine and materials science, opening a new chapter in research, education, and innovative applications.
In this collaboration, XtalPi will leverage the expertise of its AI for Science R&D platform and the extensive multimodal datasets accumulated by its robotic laboratories, combined with Microsoft's large language model (LLM) capabilities, including Azure OpenAI and its high-performance cloud computing platform. The partnership aims to explore vertical large models in the field of new drug or novel material development, with case studies developed in the area of novel material design to empower the R&D of sustainable, environmentally friendly, and highly energy-efficient new materials.
The common goal of both parties is to demonstrate how the next generation of computing and automation tools can accelerate innovation in chemistry and materials science, rapidly generate and validate AI-generated molecules that meet necessary property and functionality standards, and quickly translate research breakthroughs into competitive products.
XtalPi will also explore deploying its proprietary AI-driven molecular generation and molecular dynamics computation tools on the Microsoft Azure cloud platform to further provide robust computational support, enabling these precise and efficient intelligent algorithm tools to efficiently serve a broader range of enterprises and scientific research, driving scientific innovation on a larger scale, and continuously advancing the iterative upgrade of XtalPi's algorithms.
In addition, the two parties will explore potential cooperation in the field of educational academia, promote the introduction of experimental solutions combining advanced AI and automation technology in academic education research, and advance the digital upgrade of universities and research institution laboratories empowered by next-generation AI and robotics technology.
XtalPi's AI + Robotics platform, as an innovation hub, has become an important partner of world-renowned institutions such as MIT and Singapore’s A*STAR, providing R&D services and solutions to over 300 companies and research institutions globally.
XtalPi has rich expertise in the fields of AI, pharmaceutical R&D, and materials science, and has demonstrated outstanding performance in providing innovative solutions. Microsoft's technical strength, including robust cloud infrastructure and AI capabilities, perfectly complements XtalPi's advantages.
This collaboration comes at a pivotal moment when AI technology is profoundly transforming multiple industries, heralding a new era of enhanced innovation capabilities and efficiency. The powerful alliance between Microsoft and XtalPi, leveraging their respective comprehensive advantages and technical strengths, will not only drive advancements in the pharmaceuticals and materials sectors, setting an industry benchmark for utilizing AI to solve complex problems, but also aims to expand XtalPi's influence in the materials and education fields.
Dr. Shuhaotem Wen, Chairman of XtalPiCommented: "Microsoft has a cutting-edge research team and AI development capabilities. Our collaboration reflects a shared vision of the future, where artificial intelligence and robotics will have the opportunity to drive a new generation of innovative breakthroughs, playing a central role in addressing major issues such as human health, the environment, and energy. Through this partnership, we look forward to exploring with Microsoft how to enhance the close collaboration between AI, robotics, and human intelligence, thereby expanding our ability to understand and transform the world, and contributing to the improvement of human health and well-being."
"At Microsoft China, we are committed to leveraging the power of artificial intelligence and cloud computing"Promote innovation through volume, support breakthrough research"Dr. Yang Hou, Senior Vice President of Microsoft Global, Chairman and CEO of Microsoft Greater China RegionSaid: "Our cooperation with XtalPi has enabled both parties to advance life sciences and"Collaboration in materials science has taken a step further. By integrating AI, large language models, and robotics technology, we aim to empower the entire industry and ultimately contribute to a more innovative and sustainable future."
XtalPi was founded in 2015 by three physicists who graduated from the Massachusetts Institute of Technology. It is an innovative R&D enterprise based on quantum physics, empowered by artificial intelligence, and driven by robotics.
XtalPi adopts a combination of first-principles calculations based on quantum physics, artificial intelligence, high-performance cloud computing, and scalable and standardized robotic automation to provide drug and materials science R&D solutions and services for global and Chinese companies in industries such as pharmaceuticals and materials science (including agrotechnology, energy, new chemicals, and cosmetics).
